Leading the Long Game for Long COVID Research with Dr. Julia Moore Vogel

In this must-listen episode, Dr. Julia Moore Vogel at Scripps Research takes center stage to confer the still-emerging and always-evolving space of long COVID. As patient numbers continue to rise at an alarming rate, she makes a strong case about the critical need to better define the disease, mitigate its impact and, ultimately, break the taboo.Episode highlights0:15 Introduction1:27 Moore Vogel’s background in Long Covid4:30 Lacking terminology in Long Covid6:20 Quantifying Long Covid disease8:38 The mechanism of action: what we know10:27 Pediatric Long Covid16:00 Similarities to post-viral syndromes16:58 Key diagnostic tools18:37 The current Long Covid treatment landscape20:57 Influence of SARS-CoV-2 variants and vaccines22:02 Considering social determinants of health23:35 Needs for professional and public education27:00 Final thoughts28:28 OutroWant more Lungcast? Visit us at HCPLive.com or Lung.org.